Privia Health Group, Inc. (PRVA)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Privia Health Group, Inc. keeps $1 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 56 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Privia Health Group topped revenue estimates in the second fiscal quarter of 2026, reported on August 6 based on preliminary results, as revenue rose roughly 21% to about $632.6 million from about $521.2 million a year ago and came in at $632.6 million against a $597.3 million estimate, +5.9%. EPS was $0.07, up from $0.02 a year ago, while net income climbed roughly 237% to about $9.0 million from about $2.7 million a year ago. Gross margin and operating margin were each near 2%, with operating income at about $11.8 million, and the company posted negative operating cash flow of about $177.1 million. For the next period, consensus calls for EPS of $0.09 on revenue of $610.6 million.
About Privia Health Group, Inc.
Privia Health Group, Inc. (NASDAQ: PRVA) operates a healthcare information and services business in the United States for independent providers, medical groups, health plans, and health systems. Across FY2025, Privia Health generated $2.1 billion in revenue from software-enabled care management, administrative support, and payer-facing physician organizations.
Today's Snapshot
Yesterday PRVA fell 1.7% to 20.42.
Trading Volume
Below 10d avg (1.1M)
1M
vs S&P 500 Today
Underperforming Market
-1.25%
Updated: September 10, 2026 at 12:30 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$20.78 - $23.36Sell
- RSI (14)28.47Buy
- Stochastic %K (14, 3, 3)20.35Neutral
- MACD Level (12, 26)-0.77Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.